Molecular epidemiology and in-vitro antifungal susceptibility of Aspergillus terreus species complex isolates in Delhi, India: Evidence of genetic diversity by amplified fragment length polymorphism and microsatellite typing

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Kathuria, Shallu ^a   Sharma, Cheshta ^a   Singh, Pradeep Kumar ^a   Agarwal, Puneet ^a   Agarwal, Kshitij ^b   Hagen, Ferry ^c   Meis, Jacques F ^c,d   Chowdhary, Anuradha ^a  

^a UNIVERSITY OF DELHI   (India)

^b Rajan Babu Institute of Pulmonary Medicine and Tuberculosis   (India)

^c CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANIDULAFUNGIN; ANTIFUNGAL AGENT; CALMODULIN; CASPOFUNGIN; ISAVUCONAZOLE; ITRACONAZOLE; MICAFUNGIN; POSACONAZOLE; STEROID; VORICONAZOLE; FUNGAL PROTEIN; MICROSATELLITE DNA;

AMPLIFIED FRAGMENT LENGTH POLYMORPHISM; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; ASPERGILLUS; ASPERGILLUS HORTAI; ASPERGILLUS TERREUS; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DRUG POTENCY; FUNGAL COLONIZATION; FUNGUS ISOLATION; GENE LOCUS; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; IN VITRO STUDY; INDIA; INTERSTITIAL LUNG DISEASE; INVASIVE ASPERGILLOSIS; LUNG ASPERGILLOSIS; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POPULATION STRUCTURE; SHORT TANDEM REPEAT; ANTIFUNGAL RESISTANCE; ASPERGILLOSIS; CHEMISTRY; DNA SEQUENCE; DRUG EFFECTS; ENZYME LINKED IMMUNOSORBENT ASSAY; FUNGAL GENE; GENETIC VARIATION; GENETICS; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MOLECULAR GENETICS; PHYLOGENY;

ASPERGILLUS; ASPERGILLUS TERREUS;

AMPLIFIED FRAGMENT LENGTH POLYMORPHISM ANALYSIS; ASPERGILLOSIS; ASPERGILLUS; DRUG RESISTANCE, FUNGAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FUNGAL PROTEINS; GENES, FUNGAL; GENETIC VARIATION; GENOTYPE; HUMANS; INDIA; MICROBIAL SENSITIVITY TESTS; MICROSATELLITE REPEATS; MOLECULAR SEQUENCE DATA; PHYLOGENY; SEQUENCE ANALYSIS, DNA;

EID: 84925014496     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0118997     Document Type: Article

References (51)

1. Maertens J, Theunissen K, Verbeken E, Lagrou K, Verhaegen J, et al. (2004) Prospective clinical evaluation of lower cut-offs for galactomannan detection in adult neutropenic cancer patients and haematological stem cell transplant recipients. Br J Haematol 126: 852-860. PMID: 15352990
2. Upton A, Kirby KA, Carpenter P, Boeckh M, Marr KA (2007) Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality. Clin Infect Dis 44: 531-540. PMID: 17243056
3. Chowdhary A, Sharma C, Hagen F, Meis JF (2014) Exploring azole antifungal drug resistance in Aspergillus fumigatus with special reference to resistance mechanisms. Future Microbiol 9: 697-711. doi: 10.2217/fmb.14.27 PMID: 24957095
4. Denning D, Pleuvry A, Cole D (2013) Global burden of ABPA in adults with asthma and its complication chronic pulmonary aspergillosis in adults. Med Mycol 51: 361-370. doi: 10.3109/13693786.2012.738312 PMID: 23210682
5. Lass-Flörl C, Rath P, Niederwieser D, Kofler G, Wurzner R, et al. (2000) Aspergillus terreus infections in haematological malignancies: molecular epidemiology suggests association with in-hospital plants. J Hosp Infect 46: 31-35. PMID: 11023720
6. Baddley JW, Pappas PG, Smith AC, Moser SA (2003) Epidemiology of Aspergillus terreus at a university hospital. J Clin Microbiol 41: 5525-5529. PMID: 14662934
7. Lass-Flörl C, Griff K, Mayr A, Petzer A, Gastl G, et al. (2005) Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience. Br J Haematol 131: 201-207. PMID: 16197450
8. Lass-Flörl C, Grif K, Kontoyiannis DP (2007) Molecular typing of Aspergillus terreus isolates collected in Houston, Texas, and Innsbruck, Austria: evidence of great genetic diversity. J Clin Microbiol 45: 2686-2690. PMID: 17581930
9. Blum G, Perkhofer S, Grif K, Mayr A, Kropshofer G, et al. (2008) A 1-year Aspergillus terreus surveillance study at the University Hospital of Innsbruck: molecular typing of environmental and clinical isolates. Clin Microbiol Infect 14: 1146-1151. doi: 10.1111/j.1469-0691.2008.02099.x PMID: 19076844
10. Sutton DA, Sanche SE, Revankar SG, Fothergill AW, Rinaldi MG (1999) In vitro amphotericin B resistance in clinical isolates of Aspergillus terreus, with a head-to-head comparison to voriconazole. J Clin Microbiol 37: 2343-2345. PMID: 10364610
11. Pfaller MA, Messer SA, Hollis RJ, Jones RN; SENTRY Participants Group (2002) Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program, 2000. Antimicrob Agents Chemother 46: 1032-1037. PMID: 11897586
12. Hachem R, Gomes MZ, El Helou G, El Zakhem A, Kassis C, et al. (2014) Invasive aspergillosis caused by Aspergillus terreus: an emerging opportunistic infection with poor outcome independent of azole therapy. J Antimicrob Chemother 69: 3148-3155. doi: 10.1093/jac/dku241 PMID: 25006241
13. Lass-Flörl C, Alastruey-Izquierdo A, Cuenca-Estrella M, Perkhofer S, Rodriguez-Tudela JL (2009) In vitro activities of various antifungal drugs against Aspergillus terreus: Global assessment using the methodology of the European committee on antimicrobial susceptibility testing. Antimicrob Agents Chemother 53:794-795. doi: 10.1128/AAC.00335-08 PMID: 19064891
14. Samson RA, Peterson SW, Frisvad JC, Varga J (2011) New species in Aspergillus section Terrei. Stud Mycol 69: 39-55. doi: 10.3114/sim.2011.69.04 PMID: 21892242
15. Pringle A, Baker DM, Platt JL, Wares JP, Latge JP, et al. (2005) Cryptic speciation in the cosmopolitan and clonal human pathogenic fungus Aspergillus fumigatus. Evolution Int J Org Evolution 59: 1886-1899.
16. Rydholm C, Szakacs G, Lutzoni F (2006) Low genetic variation and no detectable population structure in Aspergillus fumigatus compared to closely related Neosartorya species. Eukaryot Cell 5: 650-657. PMID: 16607012
17. Bain JM, Tavanti A, Davidson AD, Jacobsen MD, Shaw D, et al. (2007) Multilocus sequence typing of the pathogenic fungus Aspergillus fumigatus. J Clin Microbiol 45: 1469-1477. PMID: 17376886
18. Balajee SA, Baddley JW, Peterson SW, Nickle D, Varga J, et al. (2009) Aspergillus alabamensis, a new clinically relevant species in the section Terrei. Eukaryot Cell 8: 713-722. doi: 10.1128/EC.00272-08 PMID: 19304950
19. Neal CO, Richardson AO, Hurst SF, Tortorano AM, Viviani MA, et al. (2011) Global population structure of Aspergillus terreus inferred by ISSR typing reveals geographical subclustering. BMC Microbiol 11: 203. doi: 10.1186/1471-2180-11-203 PMID: 21923908
20. Chowdhary A, Kathuria S, Xu J, Sharma C, Sundar G, et al. (2012) Clonal expansion and emergence of environmental multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR34/L98H mutations in the cyp51A gene in India. PLoS One 7: e52871. doi: 10.1371/journal.pone.0052871 PMID: 23285210
21. Chowdhary A, Agarwal K, Kathuria S, Singh PK, Roy P, et al. (2013) Clinical significance of filamentous basidiomycetes illustrated by isolates of the novel opportunist Ceriporia lacerata from the human respiratory tract. J Clin Microbiol 51: 585-590. doi: 10.1128/JCM.02943-12 PMID: 23241374
22. Hong SB, Go SJ, Shin HD, Frisvad JC, Samson RA (2005) Polyphasic taxonomy of Aspergillus fumigatus and related species. Mycologia 97: 1316-1329. PMID: 16722222
23. Glass NL, Donaldson GC (1995) Development of primer sets designed for use with the PCR to amplify conserved genes from filamentous ascomycetes. Appl Environ Microbiol 61: 1323-1330. PMID: 7747954
24. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, et al. (2011) MEGA5: Molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 28: 2731-2739. doi: 10.1093/molbev/msr121 PMID: 21546353
25. de Valk HA, Meis JF, de Pauw BE, Donnelly PJ, Klaassen CH (2007) Comparison of two highly discriminatory molecular fingerprinting assays for analysis of multiple Aspergillus fumigatus isolates from patients with invasive aspergillosis. J Clin Microbiol 45:1415-1419. PMID: 17376887
26. Rougeron A, Giraud S, Razafimandimby B, Meis JF, Bouchara JP, et al. (2014) Different colonization patterns of Aspergillus terreus in patients with cystic fibrosis. Clin Microbiol Infect 20: 327-333. doi: 10. 1111/1469-0691.12323 PMID: 23927682
27. nd ed. CLSI document M38-A2. Wayne (PA).
28. Espinel-Ingroff A, Fothergill A, Fuller J, Johnson E, Pelaez T, et al. (2011) Wild-type MIC distributions and epidemiological cutoff values for caspofungin and Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document). Antimicrob Agents Chemother 55: 2855-2859. doi: 10.1128/AAC.01730-10 PMID: 21422219
29. Espinel-Ingroff A, Cuenca-Estrella M, Fothergill A, Fuller J, Ghannoum M, et al. (2011) Wild-type MIC distributions and epidemiological cutoff values for amphotericin B and Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document). Antimicrob Agents Chemother 55: 5150-5154. doi: 10.1128/AAC.00686-11 PMID: 21876047
30. Pfaller M, Boyken L, Hollis R, Kroeger J, Messer S, et al. (2011) Use of epidemiological cutoff values to examine 9-year trends in susceptibility of Aspergillus species to the triazoles. J Clin Microbiol 49: 586-590. doi: 10.1128/JCM.02136-10 PMID: 21123534
31. Ascioglu S, Rex JH, DePauw JE, Bennett JE, Bille J, et al. (2002) Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 34: 7-14. PMID: 11731939
32. Chowdhary A, Agarwal K, Kathuria S, Gaur SN, Randhawa HS, et al. (2014) Allergic bronchopulmonary mycosis due to fungi other than Aspergillus: a global overview. Crit Rev Microbiol 40: 30-48. doi: 10. 3109/1040841X.2012.754401 PMID: 23383677
33. deShazo RD, Swain RE (1995) Diagnostic criteria for allergic fungal sinusitis. J Allergy Clin Immunol 96: 24-35. PMID: 7622760
34. Chowdhary A, Randhawa HS, Gaur SN, Agarwal K, Kathuria S, et al. (2013) Schizophyllum commune as an emerging fungal pathogen: A review and report of two cases. Mycoses 56: 1-10. doi: 10.1111/myc.12109 PMID: 23931638
35. Rüping MJ, Gerlach S, Fischer G, Lass-Flörl C, Hellmich M, et al. (2011) Environmental and clinical epidemiology of Aspergillus terreus: data from a prospective surveillance study. J Hosp Infect 78: 226-230. doi: 10.1016/j.jhin.2011.01.020 PMID: 21440331
36. Mutschlechner W, Grif K, Blum G, Lass-Flörl C (2013) Rep-PCR and RAPD-PCR fingerprinting of Aspergillus terreus. Med Mycol 51:876-879. doi: 10.3109/13693786.2013.793458 PMID: 23758105
37. Langeron M (1922) Sur un champignon d'une otomycose Brésilienne Sterigmatocystis hortai. Bulletin de la Société Pathologie Exotique 15: 383-384.
38. Raper KB, Fennell DI (1965) The genus Aspergillus. Baltimore: Williams & Wilkins.
39. Auberger J, Lass-Flörl C, Clausen J, Bellmann R, Buzina W, et al. (2008) First case of breakthrough pulmonary Aspergillus niveus infection in a patient after allogeneic hematopoietic stem cell transplantation. Diagn Microbiol Infect Dis 62: 336-339. doi: 10.1016/j.diagmicrobio.2008.06.012 PMID: 18687556
40. Klaassen CH, Gibbons JG, Fedorova ND, Meis JF, Rokas A (2012) Evidence for genetic differentiation and variable recombination rates among Dutch populations of the opportunistic human pathogen Aspergillus fumigatus. Mol Ecol 21: 57-70. doi: 10.1111/j.1365-294X.2011.05364.x PMID: 22106836
41. Hadrich I, Neji S, Drira I, Trabelsi H, Mahfoud N, et al. (2013) Microsatellite typing of Aspergillus flavus in patients with various clinical presentations of aspergillosis. Med Mycol 51: 586-591. doi: 10.3109/13693786.2012.761359 PMID: 23336695
42. Arabatzis M, Velegraki A (2013) Sexual reproduction in the opportunistic human pathogen Aspergillus terreus. Mycologia 105: 71-79. doi: 10.3852/11-426 PMID: 23074177
43. Verweij PE, Meis JF, Sarfati J, Hoogkamp-Korstanje JA, Latgé JP, et al. (1996) Genotypic characterization of sequential Aspergillus fumigatus isolates from patients with cystic fibrosis. J Clin Microbiol 34: 2595-2597. PMID: 8880528
44. Chazalet V, Debeaupuis JP, Sarfati J, Lortholary J, Ribaud P, et al. (1998) Molecular typing of environmental and patient isolates of Aspergillus fumigatus from various hospital settings. J Clin Microbiol 36: 1494-1500. PMID: 9620367
45. Tortorano AM, Prigitano A, Dho G, Biraghi E, Stevens DA, et al. (2008) In vitro activity of amphotericin B against Aspergillus terreus isolates from different countries and regions. J Chemother 20: 756-757. PMID: 19129077
46. Walsh TJ, Petraitis V, Petraitiene R, Field-Ridley A, Sutton D, et al. (2003) Experimental pulmonary aspergillosis due to Aspergillus terreus: pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B. J Infect Dis 188: 305-319. PMID: 12854088
47. Steinbach WJ, Perfect JR, Schell WA, Walsh TJ, Benjamin DK Jr. (2004) In vitro analyses, animal models, and 60 clinical cases of invasive Aspergillus terreus infection. Antimicrob Agents Chemother 48: 3217-3225. PMID: 15328076
48. Salas V, Pastor FJ, Sutton DA, Calvo E, Mayayo E, et al. (2013) MIC values of voriconazole are predictive of treatment results in murine infections by Aspergillus terreus species complex. Antimicrob Agents Chemother 57: 1532-1534. doi: 10.1128/AAC.01436-12 PMID: 23295929
49. Salas V, Pastor FJ, Rodríguez MM, Calvo E, Mayayo E, et al. (2011) In vitro activity and in vivo efficacy of posaconazole in treatment of murine infections by different isolates of the Aspergillus terreus complex. Antimicrob Agents Chemother 55: 676-679. doi: 10.1128/AAC.00736-10 PMID: 21115792
50. Pfaller M, Boyken L, Hollis R, Kroeger J, Messer S, et al. (2011) Use of epidemiological cutoff values to examine 9-year trends in susceptibility of Aspergillus species to the triazoles. J Clin Microbiol 49: 586-590. doi: 10.1128/JCM.02136-10 PMID: 21123534
51. Arendrup MC, Jensen RH, Grif K, Skov M, Pressler T, et al. (2011) In vivo emergence of Aspergillus terreus with reduced azole susceptibility and a Cyp51a M217I alteration. J Infect Dis 206:981-985.